On May 11, 2023, Xinhua News Agency, Zhejiang Provincial People's Government, China Brand Building Promotion Association, China Asset Appraisal Association and other units jointly released the "2023 China Brand Value Evaluation Information".Shengshi Baicao Pharmaceutical Co., Ltd. ranks 17th on the list of independent innovation brands with a brand value of 1.288 billion yuan.

The public welfare "China Brand Value Evaluation Information Release" jointly organized by the China Brand Building Promotion Association and relevant authoritative units is selected once a year and has lasted for ten years. It always follows international standards and national standards, adheres to the working principles of "science, fairness, openness, and recognition", and has strong authority and influence in all sectors of society. It is to establish a brand value evaluation mechanism with Chinese characteristics and create Chinese brands. Energy is an important measure to promote Chinese brands to the world.

The number of brands participating in the evaluation reached 1068, covering most of the leading enterprises in the industry.

This ranking on the 2023 China Brand Value List is the affirmation and recognition of Shengshi Baicao by the society. As a leading enterprise in the subdivided industry, Shengshi Baicao always adheres to its original mission, takes inheriting and carrying forward the culture of traditional Chinese medicine, revitalizing and developing the traditional Chinese medicine industry as its own responsibility, and is sincere in doing a good job in traditional Chinese medicine.

In the future, the company will cherish the honor, continue to adhere to the quality and responsibility, remember the original intention, forge ahead, continue to lead the high-quality development of the industry, and contribute more to the construction of Chinese brands.